Roland Schüle

Roland Schüle


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2005 in Nature
Verified
Journal Article
Open access
PDF file
EMEric Metzger
Eric Metzger
MWMelanie Wissmann
Melanie Wissmann
NYNa Yin
Na Yin
JMJudith M. Müller
Judith M. Müller
RSRobert Schneider
Robert Schneider
RSRoland Schüle
Roland Schüle
Gene regulation in eukaryotes requires the coordinate interaction of chromatin-modulating proteins with specific transcription factors such as the androgen receptor1. Gene activation and repression is specifically regulated by histone methylation status at distinct lysine residues2. Here we show that lysine-specific demethylase 1 (LSD1; also known as BHC110)3 co-localizes with the androgen receptor in normal human prostate and prostate tumour. LSD1 interacts with androgen receptor in vitro and in vivo, and stimulates androgen-receptor-dependent transcription. Conversely, knockdown of LSD1 protein levels abrogates androgen-induced transcriptional activation and cell proliferation. Chromatin immunoprecipitation analyses demonstrate that androgen receptor and LSD1 form chromatin-associated complexes in a ligand-dependent manner. LSD1 relieves repressive histone marks by demethylation of histone H3 at lysine 9 (H3-K9), thereby leading to de-repression of androgen receptor target genes. Furthermore, we identify pargyline as an inhibitor of LSD1. Pargyline blocks demethylation of H3-K9 by LSD1 and consequently androgen-receptor-dependent transcription. Thus, modulation of LSD1 activity offers a new strategy to regulate androgen receptor functions. Here, we link demethylation of a repressive histone mark with androgen-receptor-dependent gene activation, thus providing a mechanism by which demethylases control specific gene expression.

9 December 2007 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
EMEric Metzger
Eric Metzger
NYNa Yin
Na Yin
MWMelanie Wissmann
Melanie Wissmann
NKNatalia Kunowska
Natalia Kunowska
KFKristin Fischer
Kristin Fischer
RSRoland Schüle
Roland Schüle

10 June 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
DDDelphine Duteil
Delphine Duteil
EMEric Metzger
Eric Metzger
DWDominica Willmann
Dominica Willmann
PKPanagiota Karagianni
Panagiota Karagianni
NFNicolaus Friedrichs
Nicolaus Friedrichs
RSRoland Schüle
Roland Schüle
Exposure to environmental cues such as cold or nutritional imbalance requires white adipose tissue (WAT) to adapt its metabolism to ensure survival. Metabolic plasticity is prominently exemplified by the enhancement of mitochondrial biogenesis in WAT in response to cold exposure or β3-adrenergic stimulation. Here we show that these stimuli increase the levels of lysine-specific demethylase 1 (LSD1) in WAT of mice and that elevated LSD1 levels induce mitochondrial activity. Genome-wide binding and transcriptome analyses demonstrate that LSD1 directly stimulates the expression of genes involved in oxidative phosphorylation (OXPHOS) in cooperation with nuclear respiratory factor 1 (Nrf1). In transgenic (Tg) mice, increased levels of LSD1 promote in a cell-autonomous manner the formation of islets of metabolically active brown-like adipocytes in WAT. Notably, Tg mice show limited weight gain when fed a high-fat diet. Taken together, our data establish LSD1 as a key regulator of OXPHOS and metabolic adaptation in WAT.

31 October 2017 in Cancer Research
Verified
Journal Article
Open access
PDF file
EMEric Metzger
Eric Metzger
SSStella S. Stepputtis
Stella S. Stepputtis
JSJuliane Strietz
Juliane Strietz
BPBogdan-Tiberius Preca
Bogdan-Tiberius Preca
SUSylvia Urban
Sylvia Urban
RSRoland Schüle
Roland Schüle
Traditional treatments for breast cancer fail to address therapy-resistant cancer stem–like cells that have been characterized by changes in epigenetic regulators such as the lysine demethylase KDM4. Here, we describe an orally available, selective and potent KDM4 inhibitor (QC6352) with unique preclinical characteristics. To assess the antitumor properties of QC6352, we established a method to isolate and propagate breast cancer stem–like cells (BCSC) from individual triple-negative tumors resected from patients after neoadjuvant chemotherapy. Limiting-dilution orthotopic xenografts of these BCSCs regenerated original patient tumor histology and gene expression. QC6352 blocked BCSC proliferation, sphere formation, and xenograft tumor formation. QC6352 also abrogated expression of EGFR, which drives the growth of therapy-resistant triple-negative breast cancer cells. Our findings validate a unique BCSC culture system for drug screening and offer preclinical proof of concept for KDM4 inhibition as a new strategy to treat triple-negative breast cancer. Cancer Res; 77(21); 5900–12. ©2017 AACR.

6 May 2019 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
EMEric Metzger
Eric Metzger
SWSheng Wang
Sheng Wang
SUSylvia Urban
Sylvia Urban
DWDominica Willmann
Dominica Willmann
ASAndreas Schmidt
Andreas Schmidt
RSRoland Schüle
Roland Schüle

1 October 2016 in Cell Reports
Verified
Journal Article
Open access
DDDelphine Duteil
Delphine Duteil
MVMilica Vukotić
Milica Vukotić
FLFranziska Lausecker
Franziska Lausecker
HNHatice Z. Nenseth
Hatice Z. Nenseth
JMJudith M. Müller
Judith M. Müller
RSRoland Schüle
Roland Schüle
Previous work indicated that lysine-specific demethylase 1 (Lsd1) can positively regulate the oxidative and thermogenic capacities of white and beige adipocytes. Here we investigate the role of Lsd1 in brown adipose tissue (BAT) and find that BAT-selective Lsd1 ablation induces a shift from oxidative to glycolytic metabolism. This shift is associated with downregulation of BAT-specific and upregulation of white adipose tissue (WAT)-selective gene expression. This results in the accumulation of di- and triacylglycerides and culminates in a profound whitening of BAT in aged Lsd1-deficient mice. Further studies show that Lsd1 maintains BAT properties via a dual role. It activates BAT-selective gene expression in concert with the transcription factor Nrf1 and represses WAT-selective genes through recruitment of the CoREST complex. In conclusion, our data uncover Lsd1 as a key regulator of gene expression and metabolic function in BAT.